ATRX and glioblastoma: The chromatin remodeler ATRX and the histone chaperone DAXX are mutated in a variety of cancers, including glioblastoma multiforme, pediatric adrenocortical carcinoma, osteosarcoma, neuroblastoma, myelodysplastic syndrome, acute myeloid leukemia, and PNETs [180].